Speakers

Our successful choice of high quality speakers is what allowed Master Investor to build up such a loyal following. For 2017, we upped the game yet again and we had signed up a whole number of high profile speakers for our main stage, as well as an unprecedented number of companies that were presenting themselves in the Gallery Suite, on our Rising Stars Stage and in the Auditorium. Both in terms of the quality of our speakers as well as the number of companies presenting, Master Investor is the industry’s market leader.

Justin Urquhart Stewart

JUSTIN URQUHART STEWART, CO-FOUNDER AND HEAD OF CORPORATE DEVELOPMENT
DAVID CARROLL, HEAD OF STRATEGY

Seven Investment Management | 10:05 – 10:35

Talk Title: Has the investment market gone mad – what are you going to do now?

Justin Urquhart Stewart: With an early career that spanned the vineyards of Europe, the docks of Southampton and finance in Asia, Justin went onto establish Broker Services at what became Barclays Stockbrokers. Today he is one of the most recognisable and trusted market commentators on television, radio and in the press. He is also one of the co-founders of 7IM.

Together with Tom Sheridan, Justin founded 7IM to deliver radical common sense in an industry where that quality is hard to find. As Head of Corporate Development, he ensures the principle of doing the right thing is as powerful today as it was at the outset. As an enthusiast of financial education and service, he is a champion of providing clients the very best, clearly expressed.

David Carroll: For nearly 30 years, David has been focusing on client relationships, which probably reveals everything that matters about his service belief system. Working with Justin and Tom, man and boy at Barclays Stockbrokers and Prudential Bache, he was also one of the original ‘seven’.

As Head of Strategy, David is ensuring that as 7IM grows, it does so in a way that continues to focus single-mindedly on the client. Never one to be far away from what really matters, he also continues to be a practitioner, holding true to the principle that he’d never suggest anything he wouldn’t do himself: in investment matters at least.

Seven Investment Management company profile

Jim Mellon

JIM MELLON

11:45 – 12:30

Talk Title: The Long View – Investing in Longevity

Headline speaker Jim Mellon is famous for notching up the biggest ever success on the AIM market with Uramin, the company he co-founded in 2005 with $100,000 and sold in 2007 for $2.5 billion. With a substantial international property portfolio and interests in a variety of companies, particularly in the alternative energy and biotech sectors, Jim is a highly experienced and successful investor whose expert views were closely followed at last year’s Master Investor Show and will undoubtedly draw a large crowd again this year. With 96% of 2014 attendees rating his talk Good or Excellent, he’s sure to draw big crowds again.

Jim Mellon

SPECIAL GUEST: ARRON BANKS, ELDON INSURANCE GROUP INTERVIEWED BY: SWEN LORENZ, MASTER INVESTOR LTD.

Eldon Insurance Group | 12:30 – 12:50

Talk Title: The use of Artificial Intelligence in Social Media

As serial entrepreneur in the insurance sector, Arron Banks has built a business empire from virtually nothing. He is also an avid private investor, counting stakes in diamond mines in Africa among his investments. He even once worked as consultant for Warren Buffet’s Berkshire Hathaway, and keeps a framed $5 bill signed by Buffet in his office. The signed bill hangs alongside a certificate for a single Berkshire Hathaway share that he purchased for $85,000 a decade ago and which is now worth $260,000 – testament to his foresight!

Having recently made a name for himself as financial backer of the Leave.EU campaign, Banks can count unique experience in using social media for corporate communication among his skills. In less than 12 months, he built a social media movement that eventually reached 30m people across the UK. Building on the experience gained during this campaign, Banks is now planning to turn Eldon Insurance into “the world’s most technologically advanced direct insurance group”.

How does the growing use of social media (and artifical intelligence) affect private investors, which investment opportunities arise out of these changes, and how will politics continue to influence investment returns?

Arron will share some of his insights in a 20 minute Main Stage interview hosted by Master Investor’s Swen Lorenz.

Tom Stevenson

TOM STEVENSON, INVESTMENT DIRECTOR

Fidelity International | 13:30 – 14:00

Talk Title: The 7 things you need to know in 2017

Presentation Synopsis: If you thought 2016 was an interesting year to be an investor, you haven’t seen anything yet. 2017 promises more political uncertainty, more economic surprises and more unexpected market responses. That’s bound to create a wealth of opportunity for smart investors. Tom Stevenson highlights the seven key themes that he expects to drive investment returns this year and suggests the best way for investors to profit from them.

Tom joined Fidelity in 2008. A spokesman and commentator on investments, Tom is responsible for defining and articulating investment strategy for Fidelity’s Personal Investing business. Widely quoted in the national press and appearing regularly on radio and television, Tom is a sought-after expert on markets, investment trends and investment funds. He is a weekly columnist in the Daily Telegraph, and regularly appears on BBC News, Sky and major radio stations. Prior to joining Fidelity, Tom was a financial journalist working for publications including Investors Chronicle, the Independent and the Daily Telegraph.

Fidelity International company profile

Alex Wright

ALEX WRIGHT, PORTFOLIO MANAGER

Fidelity Special Situations | 14:45 – 15:15

Talk Title: Opportunity in uncertainty

Presentation Synopsis: Alex Wright, manager of Fidelity Special Situations, explains his contrarian investment approach, and the unfashionable areas of the market he is finding attractive today. He will describe the attributes he looks for in potential investments, and some examples of companies which currently meet his strict criteria. He will also illustrate how volatility and uncertainty can create good opportunities for diligent and contrarian stock pickers.

Alex Wright has honed his distinctive contrarian value investment approach over a career spanning more than 15 years with Fidelity International.

He joined the company in 2001 as a research analyst, covering a number of UK and European equity sectors across the market capitalisation spectrum in the years to follow.

He has managed the Fidelity Special Situations Fund since January 2014 and has been portfolio manager of the Fidelity UK Smaller Companies Fund since its launch in February 2008. He has also been responsible for managing Fidelity Special Values PLC since September 2012.

Alex has a BSc in Economics from Warwick University, where he graduated with First Class Honours, and he is also a CFA Charterholder.

Fidelity International company profile

Gonçalo de Vasconcelos

GONÇALO DE VASCONCELOS, CEO AND CO-FOUNDER; FEATURING SPECIAL GUEST, JIM MELLON

SyndicateRoom | 16:20 – 16:50

Talk Title: Early-stage equities: the new home of post-Brexit returns?

Gonçalo is the CEO and co-founder of SyndicateRoom and a contributor for Forbes and has been considered one of the Top 40 most influential people in fintech in Europe. He pioneered the investor-led™ model in the UK, opening up access to exclusive deals that professionals are investing in. His leadership is driven by his vision for fair and transparent access to investments by all investors – big and small, institutional and private investors.

Gonçalo is an alumni of Imperial College London (awarded distinction) and has an MBA from Judge Business School, University of Cambridge where he was awarded several awards for academic and professional achievements.

Gonçalo is also a contributor for Forbes, writing regularly about fintech, entrepreneurship, corporate finance and early stage investments and speaks regularly at public events on the same themes.

In his spare time Gonçalo cycles long distances, plays tennis and, when in warmer climates, sails with his wife whenever there is half a chance.

SyndicateRoom company profile

SCOTT GRANT

London South East | 09:20 – 09:30

Talk Title: lse.co.uk – How it assists your Trading & Investing

Previously an Independent Financial Advisor (IFA), Scott brought relevant and insightful expertise to www.lse.co.uk upon joining the company as a Director in 2007.

Since then, www.lse.co.uk has grown its offering to Private Investors and become one of the foremost financial portals in the U.K.

With a belief in the simple and clean presentation of relevant financial information, Scott is committed to a ‘Customer first’ ethos in continuing to build www.lse.co.uk.

London South East company profile

Alpima | 09:30 – 09:40

Zenith Resources | 09:40 – 09:50

KIRAN MORZARIA

Rare Earth Minerals Plc | 09:50 – 10:00

Kiran holds a bachelor of engineering (industrial geology) from the Camborne School of Mines and an MBA (finance) from Cass Business School. He has extensive experience in the mineral resource industry working in both operational and management roles. Kiran spent the first four years of his career in exploration, mining and civil engineering. He then obtained his mba and became the finance director of Vatukoula Gold Mines and was part of the team that acquired and re-commissioned operations. He has served as a director of a number of public companies in both an executive and non-executive capacity.

Rare Earth Minerals Plc company profile

RICHARD WOLANSKI, FINANCE DIRECTOR

Avation Plc | 10:40 – 11:00

Talk Title: Avation Plc: Celebrating 10 years as an Aircraft Lessor

Mr Richard Wolanski, B.Com, ACA, is a Chartered Accountant and his qualifications include a Bachelor of Commerce from the University of Western Australia. Mr Wolanski has extensive professional experience in the international finance industry. He has provided corporate, strategic and financial advisory assistance to public companies in Australia, Singapore and the United Kingdom. Mr Wolanski has significant corporate experience during his career serving in a range of Executive Director Chief and Financial Officer Company roles. In his current role as Finance Director at Avation Plc he is primarily responsible for maintaining access to capital.

Avation Plc company profile

GUY MYLES, FOUNDER AND CHIEF EXECUTIVE

Flying Colours | 11:00 – 11:10

Talk Title: How to increase your returns by 35%

Guy founded Flying Colours in 2014. He was determined that quality financial advice and investment management should be better value and accessible to more people across the UK. At Flying Colours he is joined by a team with many years’ experience in the financial advice and investment industry.

Previously, in 2000, Guy co-founded Octopus Investments, a UK fund management company with over £5bn of assets under management. Before that, he was a fund manager for Mercury Asset Management between 1994 and 2000.

Flying Colours company profile

GRAHAM LUMSDEN, CEO

Motif Bio | 11:10 – 11:20

Talk Title: Iclaprim-a novel antibiotic for serious and life-threatening infections

Graham G. Lumsden, Chief Executive Officer of Motif, is responsible for all aspects of the strategy, management, and operations of the Company. Prior to joining Motif, Mr. Lumsden was a senior executive at Merck & Co., Inc. where he held commercial leadership positions in worldwide businesses including contraceptives and osteoporosis. Mr. Lumsden has a proven record of success leading change and delivering results in subsidiary and global leadership positions, including new product launches, pre-clinical/clinical development, regulatory strategy, cross-functional team leadership, IP strategy/litigation, and domestic/international sales and marketing. Mr. Lumsden is a member of the Royal College of Veterinary Surgeons (MRCVS), holds a postgraduate diploma from the Chartered Institute of Marketing (MCIM), and is a dual citizen of the U.S. and UK.

Motif Bio company profile

TIM MCCARTHY, FCCA, MBA, NON-EXECUTIVE CHAIRMAN

ImmuPharma Plc | 11:20 – 11:30

Talk Title: Unlocking the Value in Lupuzor™

Mr McCarthy has a 35 year international business career in high growth biotech, healthcare and technology companies. He is currently Chairman and Non-Executive Director for a number of biotech and healthcare related companies, including Incanthera, Harvard Healthcare and Expedeon Holdings. With a core understanding of AIM and its regulatory processes Mr McCarthy has helped raise substantial amounts of equity capital and also advised and worked at Board level for a diverse range of companies internationally. These areas include business strategy, mergers & acquisitions, due diligence and licensing.

ImmuPharma Plc company profile

SIMON DANIEL, FOUNDER

Moixa | 11:30 – 11:40

Talk Title: Moixa – Energy Storage a major equity and asset growth class

Moixa is the UK leader in the home energy storage market, sometimes referred to as a British Tesla – but producing smart batteries and solutions for the mass-market. Moixa works with Utilities and Grid to deliver a range of solutions that help reduce infrastructure costs and enable better customer propositions. Moixa will talk about sector opportunities, and also how personal investment in household solar, storage and efficiency technologies, can deliver savings.

Simon Daniel is a serial innovator, and founder of Moixa – a UK pioneer in new energy R&D, Distributed Energy Storage, and DC Microgrids. Moixa is the UK leader in home energy storage and VPP/Aggregate storage models, with over £5m of UK delivery across Utilities, DECC, Networks. Simon also joined the former PM at the Northern Future Forum to discuss new Energy Pension finance model for behind meter assets. Simon holds multiple patents on advanced mobile interfaces, consumer and smart battery technologies. He was previously at Accenture as a senior manager/tech evangelist and holds an MA in Physics from Cambridge, attended the inaugural Singularity University Summer in 2009.

Moixa company profile

MATISS ANSVIESULIS, CO-FOUNDER & CEO

Creamfinance | 13:00 – 13:10

Talk Title: Creamfinance: Smart Data, Simple Loans

A highly analytical, business multilingual entrepreneur with passion for growing startups to an impactful business. Matiss Ansviesulis is a Co-Founder and the CEO of the fastest growing European Fintech Creamfinance, providing personal finance products in emerging markets. After completing studies at Lancaster University’s Management School and working as a business analyst for JP Morgan in London, he founded Creamfinance in 2012 based on a vision to implement an innovative Smart data-driven consumer finance company that would focus on machine-learning capabilities to quickly evaluate and score. Having started business from nothing, within 5 years he managed to grow the company to €35M revenue business employing over 220 people and operating in 7 countries both within and outside of Europe.

DAVID LENIGAS

Doriemus Plc | 14:05 – 14:15

Talk Title: Oil under the M25

Mr Lenigas, Executive Chairman of Doriemus Plc – was also, until recently, the executive chairman of London listed UK Oil & Gas Investments Plc, which was responsible for the new Horse Hill oil discovery near London’s Gatwick International airport that flowed on test a UK onshore record of 1,688 barrels of oil per day. He is now the executive chairman of London listed Doriemus Plc, which owns an interest in the horse hill oil discovery and is working with its jv partners towards moving horse hill into production.

Doriemus Plc company profile

WiseAlpha | 14:15 – 14:25

MARK BILLINGS, PRESIDENT

Auxico Resources Canada Inc. | 14:25 – 14:35

Talk Title: Zamora – High-grade silver and gold in Mexico

Mark Billings is the President and a Director of Auxico Resources Canada Inc., which has 100% ownership of the Zamora silver-gold property in the state of Sinaloa, Mexico. Since 2000, Mark has worked in investment banking, raising funds for companies such as Auxico, as well as taking companies public. He has also served as an officer or director of publicly traded resource companies. He has a Bachelor of Arts (Highest Honours) in Political Science from Carleton University (Ottawa, Canada), an MBA from the Harvard Business School and a Chartered Financial Analyst (CFA) designation.

Auxico Resources Canada Inc. company profile

MARK FOLIGNO, PRODUCER / CONSULTANT

Carnaby International | 15:15 – 15:25

Mark has first hand knowledge of what it takes to build a successful business in the media sector. In 2003, he bought Molinare transforming it into one of the largest privately owned post-production companies in the UK, a power house in high end TV drama and feature film, tripling turnover. He also co-produced and executive produced projects such as BAFTA winning Moon, and OSCAR and BAFTA award winning The King’s Speech. Since selling Molinare in 2011, Mark’s film and tv credits include The Rise (aka Wasteland), Golden Years and The Retreat, aired on BBC2 over 5 nights in a primetime slot and hosted by Nick Knowles. All of these projects have sold in territories around the world. He is currently working on a number of film and tv projects.

Carnaby International company profile

ANDREA CATTANEO, CHIEF EXECUTIVE OFFICER

Zenith Energy | 15:25 – 15:35

Talk Title: The Great Opportunity in Azerbaijan

Andrea Cattaneo is CEO & President of Zenith Energy Ltd., a Canadian international oil & gas production company with gas concessions in Italy and a production sharing agreement (PSA) with SOCAR, State Oil Company of the Azerbaijan Republic, for the largest onshore oilfield of Azerbaijan.

Has an extensive energy resources and financial background with 30 years of experience in sovereign loans, capital markets, and oil trading between Western and emerging countries.

Mr. Cattaneo has served as an advisor to many governments, specifically former Soviet Union countries.

Zenith Energy company profile

DR. LINDSAY WU, CHIEF SCIENTIFIC OFFICER

15:35 – 16:05

Talk Title: Mortality is not a certainty: diversified investing to extend human lifespan and treat disease

Dr Wu is a prominent scientist and academic entrepreneur in the fields of metabolic biochemistry and the biology of ageing. He heads the Laboratory for Ageing Research at UNSW Australia, and is also the Chief Scientific Officer of Hydra Capital, where he is developing new therapies to treat ageing and extend human longevity, whilst also using these to treat common therapeutic indications, to accelerate immediate returns on investment. He runs a diversified research incubation platform with multiple teams working on different molecular mechanisms to extend lifespan and treat disease.

Hydra Capital company profile

AMANDA VAN DYKE

Peterhouse Capital | 10:40 – 10:50

DAVID BUDGE, MANAGING DIRECTOR AND CO-FOUNDER

Aurora Labs | 10:50 – 11:10

Talk Title: Printing Money

David Budge is the creative driver, Managing Director and Co-Founder of Aurora Labs Ltd, an Industrial technology and innovation company that specialises in the development of 3D metal printers, powders, digital parts and their associated intellectual property based in Perth, Western Australia. He is the primary inventor of the large majority of Aurora’s inventions that are the subject of its patent applications. His extensive industry experience combined with his urge to innovate have helped him lead Aurora from strength to strength since publicly listing on the ASX in August 2016.

Aurora Labs company profile

YONI ASSIA, CEO

eToro | 11:10 – 11:20

Talk Title: CopyFunds – the next generation investment product

Yoni Assia is CEO at eToro. He has been passionate about finance and computer science from a young age, and decided to combine them into one: During the Web 2.0 revolution, he founded eToro, the world’s leading social trading network. It’s Yoni’s vision to disrupt the financial industry and be a leader in the fintech revolution. Yoni is a member of the YPO, and was included in Financial News’ Fintech 40 list, and City A.M.’s Fintech 100 top influencers. Yoni holds a B.Sc. in Computer Science and Management and an MSC in Computer Sciences.

eToro company profile

HARRY BERRY, NON-EXECUTIVE DIRECTOR AND COO

CyanConnode | 11:20 – 11:30

Harry joined the Board in May 2014. He has over 30 years’ experience in the technology and telecommunications industries and has held a wide range of senior positions and responsibilities in sales, global product management, change management, and development programs.

Harry joined BT in 1970 and was responsible for the creation of BT Brightstar, a corporate incubator focussing on BT’s R&D portfolio to create technology venturing. Harry is currently European Partner with New Venture Partners, a global venture capital firm dedicated to corporate technology spinouts with over $700 million under management.

He is also the Chairman of the Eastern Enterprise Hub, which is an organisation responsible for delivering entrepreneurship into academic establishments working with the University Campus Suffolk and colleges across the eastern region of England. Harry is also the Chairman of New Anglia Capital, which helps to provide funding for early stage businesses.

CyanConnode company profile

MARK CHILD, CHAIRMAN AND CEO

Condor Gold Plc | 11:30 – 11:40

Talk Title: Building the next gold mine in Nicaragua and proving a world class Gold District

Joined the Board of Condor Gold plc on the 24th May, 2006 as a non executive Chairman. Following the moratorium of all mining in El Salvador in 2008, Mr Child successfully repositioned the company in Nicaragua, acquiring 100% of ten concessions. Mr Child is the largest shareholder with 8.5% of Condor Gold. He has provided the leadership from no resource to 2.5m oz gold resource, maiden reserves and permitting, spending 25% of his time in Nicaragua.

Mr. Child is a versatile, entrepreneurial senior executive with a speciality in emerging markets. He worked for 20 years in equity capital markets as an institutional stockbroker and in corporate finance/private equity. At board level Mr. Child has been an executive director of Hong Kong listed Regent Pacific Group, an emerging market fund manager and private equity group. He has been a Non Executive director of several private companies.

CyanConnode company profile

JAY LAKHANI, CEO

Visulytix | 13:00 – 13:10

Talk Title: AI in Clinical Decision Support Systems

Jay Lakhani graduated from the University of Oxford with a Masters in Engineering, where he developed a strong interest in artificial intelligence, applying such techniques to MRI brain imaging. Before Visulytix, he worked in financial services as a buy-side equity research analyst at Principal Global Investors.

Visulytix Ltd company profile:

Visulytix applies cutting edge deep learning techniques to medical image analytics to provide an artificial intelligence powered decision support system. These systems are then integrated into innovative workflows which improves the accuracy and the quality of diagnosis all whilst reducing the cost of care to the provider. It is increasingly clear that such solutions are required as the burden on healthcare systems around the world begins to take its toll.

PROFESSOR MICHAEL GRANT WYLLIE, PHD, DSC, CHIEF SCIENTIFIC OFFICER, REGENT PACIFIC GROUP; EXECUTIVE DIRECTOR, PLETHORA SOLUTIONS LTD.

Regent Pacific Group Limited | 14:05 – 14:15

Talk Title: Regent Pacific a major player in Sexual Health today and tomorrow.

Prof Wyllie has particular responsibility for the process of securing approvals of the product, regulatory compliance and assisting the Chief Executive Officer in the commercial development of Fortacin of Plethora Solutions Holdings plc (“Plethora”). Prof Wyllie is a co-founder of Plethora. He has over 30 years of experience in senior management level positions within the pharmaceutical industry, with Wyeth and Pfizer. He has considerable hands-on experience in all aspects of the drug discovery and development process, and has been involved with new project inception, drug discovery and safety testing, early and late stage clinical development, regulatory filing, and the successful commercialisation of products, including Cardura® (doxazosin), Enablex® (darifenacin) and Viagra® (sildenafil). Prof Wyllie sits on the Clinical Trial Design and Future Therapies in BPH Committees of the World Health Organisation International Consultations on Urological Disease and the International Advisory Panel to The University of Strathclyde. He is an assistant editor of the British Journal of Urology in the Sexual Medicine Section. He has over 200 publications and is the named inventor of over 80 patents. He is an independent director on the board of the NASDAQ listed reproductive health company, Repros (RPRX).

The talk will feature predominantly on activities within Plethora Solutions covering the EU launch by Recordati and progress on US submission and out-licensing. In addition there will be some discussion on potential future activities in Sexual Health and the Diabetic Boot Company.

Regent Pacific Group Limited company profile

MARK TAYLOR, CHIEF CUSTOMER OFFICER FOR EQUINITI

Selftrade | 14:15 – 14:25

Talk Title: ETF’s Rising Stars

Mark has recently moved into the newly created role of CCO and is a member of the Equiniti Group Executive, looking after 25 million customers.

Since joining Equiniti in 2009 with overall responsibility for its regulated business including Selftrade, Mark’s new role will see him focusing on consumer proposition and customer experience.

Mark has over 30 years’ experience in the financial services industry and was previously Director at Virgin Money and has held senior positions at Fidelity and Charles Schwab.

Selftrade company profile

RICHARD HICKMAN, DIRECTOR, INVESTMENT AND OPERATIONS

HarbourVest Global Private Equity Limited | 14:25 – 14:35

Talk Title: Targeting long-term growth through access to private companies

Richard joined HarbourVest in 2014 to focus on the activities of HarbourVest Global Private Equity Limited, a closed-end investment company that invests in and alongside HarbourVest-managed funds. He joined the firm after seven years with 3i plc, where he served as a manager in the business planning and analysis group. Richard’s experience also includes working as a manager in Deloitte’s finance and operations management team in London. Richard is a member of the Chartered Institute of Management Accountants and received a BSc in Economic History from the London School of Economics and Political Science in 2001.

HarbourVest Global Private Equity Limited company profile

LUCIUS CARY AND ANDREA MICA

Oxford Technology | 15:15 – 15:25

Talk Title: Investing through the Oxford Technology (S)EIS Fund.

Lucius Cary is the founder and managing director of Oxford Technology, which has specialised in making and managing investments in start-up technology-based businesses since 1983.

Prior to joining Oxford Technology, Andrea Mica worked in the entrepreneurial, technology and investment field – technology licensing, growing technology companies and identifying new technologies to invest in.

The SEIS scheme offers super-generous tax reliefs for taking the risk of investing in start-ups. The key to success (mathematically speaking) is to invest in high-risk high reward start-ups. The losses on the failures are all-but eliminated by the initial tax reliefs and later, loss relief. The gains of the winners are tax free.

But despite knowing that this is the best strategy from a mathematical viewpoint, most investors find it hard to make genuinely high risk investments high reqward investments when it comes to the point. The temptation to invest in ’safe’ investments is often too great to resist.

Oxford Technology has specialised in investing in technology start-ups since 1983, and technology start-ups are probably the riskiest of all forms of investment. There are so many things which can and do go wrong. But the other side of the coin, is that the gains can be very large when things go well.

So the maths says that this strategy should work.

And, four years into the fund, everything is looking good. Full details on www.oxfordtechnology.com

Perhaps our most distinguishing feature as investors is that all our investments are near Oxford and we get actively involved, usually by means of frequent informal meetings, to help our investees. The scientists in whom we invest may be future Nobel laureates but they probably won’t have completed a VAT return or negotiated a deal with a US distributor before.

Oxford Technology company profile

KERIM DERHALLI

investr | 15:25 – 15:35

Kerim Derhalli is the Founder & CEO of invstr Ltd. invstr’s mission is to democratise access to financial information using fintech, edtech and gamification. Kerim has a passion for investment, financial markets, finance empowerment, business design, and using diversity and collaboration to create high performing teams.

Kerim Derhalli has a thirty year track record of building, growing and managing multi-billion dollar businesses at leading financial institutions all around the world. These roles have spanned the Equity, Commodity, Credit, Fixed Income, Foreign Exchange, Derivative and Emerging Market asset classes. Prior to founding invstr, Kerim was Global Head of Equity Trading at Deutsche Bank.

Kerim has lived and worked in Europe, the USA, the Middle East, Japan and Singapore. He holds a B.A. and M.A. in Philosophy, Politics and Economics from Oxford University. He was an Exhibitioner of Magdalen College, Oxford, an English Speaking Union Scholar, a St. Paul’s School Senior Foundation Scholar, and a Trotman Junior Exhibitioner.

Investr company profile

Cryptocompare | 15:35 – 15:45

ALEX ZHAVORONKOV, PHD, CEO

Insilico Medicine | 15:45 – 15:55

Talk Title: Artificial intelligence for drug discovery, biomarkers development and aging research

Alex Zhavoronkov, PhD, is the CEO or Insilico Medicine, Inc, a company applying latest advances in deep learning to drug discovery and biomarker development headquartered at the Emerging Technology Centers on the campus of the Johns Hopkins University in Baltimore and the CSO of the Biogerontology Research Foundation, a UK-based registered charity supporting aging research worldwide. The company is focusing on applying deep learning and advanced signaling pathway activation analysis to biomarker discovery, drug discovery and drug repurposing for aging and age-related diseases. Dr. Zhavoronkov is the co-founder and CSO of Beauty.AI, the first beauty contest judged by robot jury, co-founder of AgeNet competition on deep learned biomarkers of aging, co-founder of Diversity.AI, a think tank dedicated to preventing racial and age bias in AI. He is also the director of the International Aging Research Portfolio (IARP) knowledge management project and head of the Regenerative Medicine Laboratory at the Federal Clinical Research Center for Pediatric Hematology, Oncology and Immunology, one of the largest children’s cancer centers in the world performing over 300 bone marrow transplantations annually since 2012. He is the adjunct professor of the Moscow Institute of Physics and Technology. His primary research interests include artificial intelligence, deep learning, GPU computing, systems biology of aging, regenerative medicine, next-generation sequencing and non-invasive prenatal and cancer diagnostics. He holds two Bachelor Degrees from Queen’ s University, a Masters in Biotechnology from Johns Hopkins University, and a PhD in Biophysics from the Moscow State University. From 2011 to 2016 Dr. Zhavoronkov published over 60 peer-reviewed research papers and two books “The Ageless Generation: How advances in biomedicine will transform the global economy” (Palgrave Macmillan, 2013) and “Dating AI: a guide to falling in love with artificial intelligence” (RE/Search Publications, 2012). Prior to switching his focus to aging research in 2004, he served as the director of Central and Eastern Europe at ATI Technologies, publicly-traded leader in computer graphics processing technology acquired by AMD (Nasdaq:AMD) and was the co-founder of and heads NeuroG, a neuroinformatics company utilizing machine learning techniques to analyze EEG and fMRI data. He is the editor of Aging, associate editor of Frontiers in Genetics and review editor of Frontiers in Molecular Biosciences and is co-organizing the EMBO Practical Applications of Aging Research forum and the Artificial Intelligence Forum at the Basel Life Science Week, one of Europe’s largest industry events in drug discovery.

Insilico company profile

Humaniq | 15:55 – 16:05

Humaniq company profile

MIKE READ, CO-FOUNDER, PELICAN TRADING

Pelican Exchange | 10:05 – 10:30

Talk Title: How to identify and connect with the best mentors, educators and pro-traders

Mike has spent his entire career in Financial Technology (FinTech) and Financial Services, originally starting his career as a Corporate Financier specialising in M&A activity in the financial services sector. Mike has turned his hobby – designing trading platforms – into his core specialisation, heading up the product team at Pelican. Mike is a regulated member of the FCA and is a qualified Fund Manager.

Pelican Exchange company profile

JAMES SORE, CHIEF INVESTMENT OFFICER

SyndicateRoom | 10:40 – 11:10

Talk Title: Free Lunch

As Chief Investment Officer at SyndicateRoom, James started his career at a boutique investment firm, originally as investment analyst and quickly moving to investment manager. He’s also built up his own private investment portfolio, while starting and selling companies. James is also a mechanical and electronics engineer with experience designing and developing products for world-leading brands such as Coca-Cola, Hershey’s, Pfizer and British American Tobacco.

SyndicateRoom company profile

EVIL KNIEVIL

11:10 – 11:40

Talk Title: Free-form Q&A

Evil Knievel, the well-known and respected industry figure answers your burning questions around Shares and Sectors. Come along to this less regimented – and no doubt insightful – session!

ROD THOMAS FCA, MANAGING DIRECTOR

Avantis Wealth | 12:50 – 13:30

Talk Title: The FRESH Investment Strategy Reveals Three Investments That Offer Exceptional Returns of 10% – 44% Annually!

“I’m passionate about creating financial freedom through alternative investment. I’ll help you profit more from your assets and retain more of what you create.”

Rod qualified as a Chartered Accountant in the 1970s, and is a serial property investor and developer. He is the author of three investment related books including “How to Use the FRESH Investment Strategy to Achieve 7-15% Net Annual Returns”. Rod is the Managing Director of Avantis Wealth, one of the UK’s fastest growing investment brokers. An in-demand key speaker at national events, he challenges traditional wealth managers through his non-conformist and revolutionary FRESH Investment Philosophy.

Avantis Wealth company profile

DAVID PAUL

VectorVest | 14:05 – 14:35

Talk Title: Combine Fundamental and Technical Analysis to pinpoint highly profitable trades on the London Stock Exchange

David Paul has been trading in the financial markets since 1982 and as a self-supporting trader since 1988. He is a qualified Mechanical Engineer with a PhD in applied Mathematics. His first job after University was with mining firm Anglo and was Head of Research for an Anglo subsidiary named Boart International prior to becoming a full time trader. In 1990 he began to move from unleveraged share trading to short term leveraged trading of the Ft100 contract and in the last 10 years to trading in the Foreign Exchange markets. His plan is to make cash from short term trading and to invest that cash in companies that are growing earnings both aggressively and safely. It’s the same model that Soros used in the Quantum Fund. In 1992 after speaking at an investment club he was asked to train a group of traders and this lead to a second career as a trading coach and mentor. Over the last 20 plus years he has done seminars in trading of stocks, futures and Forex all over the world. These seminars have been conducted at both retail and institutional level. In 2008 along with Tom Hougaard he started WhichWayToday. The company gives real time calls in stock indices and Forex markets. He still trades there and lends a hand when the full time traders needs a break. While in London during 2010 trading at Whichwaytoday he discovered the power of the VectorVest stock market trading program. He started there as a customer but became so happy with the product that he is, at the time of writing, the MD of VectorVest UK and VectorVest SA. He continues to trade short term for cash and to bank that cash into more solid longer term UK shares for both growth and dividend income using the VectorVest methodology.

VectorVest company profile

PAUL MAHONEY, FOUNDER & MANAGING DIRECTOR

Nova Financial | 14:45 – 15:15

Talk Title: Property vs Shares; The age old question! Which asset class is best?

Presentation Synopsis: This seminar will answer the age old question, should you invest in property or shares? It will compare the two with regards to returns, stability, suitability for different situations and goals and more. It will feature a particular focus on the use of each option in providing for a comfortable retirement.

Paul is the Founder and Managing Director at Nova Financial, an independent advisory company that specialise in property investment and finance. He has successfully advised thousands of property investors both in person and through his educational books. Paul is a recognised property and finance expert, commentator, landlord, financial advisor and key note speaker. He delivers many seminars and talks a year throughout the UK and overseas, he is also commonly featured in the media in leading publications and on television.

Nova Financial company profile

MODWENNA REES-MOGG, CEO & FOUNDER

AngelNews | 15:20 – 15:35

Modwenna has worked in corporate finance, business angel investment and venture capital for more than 20 years. In 2003 she founded AngelNews, a leading information provider and commentator on the early-stage funding market in the UK.

She is a Non-Executive Director of Albion Technology & General VCT and of Asset Match, a co-founder of CrowdRating, and runs The Pluralists Club for senior executives developing and running portfolio careers (www.thepluralists.club). She has published several books including: ‘Crowdfunding, How to raise money and make money in the crowd’ and ‘Dragons or Angels’, a handbook for people wanting to become or raise money from business angels.

RAJAN DHALL, MARKET ANALYST

London South East | 15:35 – 16:05

Technical Seminar: Introduction to Level 2 / Charting

Rajan Dhall is a full time Market Analyst. He has been trading/investing professionally since 2007; managing various funds producing exceptional returns. He is a full member for the Society of Technical Analysts; holding the prestigious MSTA designation, and is also a Chartered Financial Technician with the International Federation of Technical Analysts.Rajan has vast experience of research, developing, and testing complex trading systems focusing on the equity, futures, and foreign exchange markets. He also provides market commentary services to many dedicated investors, traders, financial institutions, and hedge funds. Rajan believes psychology is the key to trading success.

London South East company profile

SEAN KEYES, EDITOR OF THE PENNY SHARE LETTER

Agora UK | 16:20 – 16:50

Talk Title: Avoiding average: four steps to really grow your wealth in the stock market

For many years Sean worked with MoneyWeek, managing their investment newsletters, before he left to join Agora Financial UK as the head of their growth franchise.Sean has since appeared on Share Radio, TIP TV and writes Risk and Reward, a free email newsletter published daily to over 30,000 private investors. However, Sean is best known as the editor of the popular Penny Share Letter, an investment advisory newsletter with over 7,000 readers.